Conference Day Two: 22nd October 2008

08.45 Chairperson’s Opening Remarks

09.00 Developing An Integrated Strategic Plan To Protect Your Product

In this session you will hear how Johnson & Johnson develops a brand protection plan for a new product launch. Through the use of a case study this session will address:

• Assessing the risk of counterfeit, diversion or tampering of a new product
• Identifying the specific vulnerabilities that can be addressed to mitigate those risks
• Developing a strategic plan to improve the security of your product in the market
• Creating a playbook to implement that plan
• Implementing a market monitoring program to gauge results, and improve efforts

Tracy Hassan
Director of Global Brand Protection
Johnson & Johnson Health Care Systems Inc.

09.45 Common Coding Standards In The NHS - Where Patient Safety Meets Commerce

The Department of Health in the UK recommends that the GS1 coding standards should be adopted throughout the healthcare system in England, both for manufactured products and for coding systems used within the healthcare settings. This policy is supported by the NHS Procurement eEnablement Programme, of which a key aim is to establish common coding standards across the NHS supply chain. This presentation will look at how the NHS is working with GS1 UK to achieve this and realise benefits for patient safety.

Rachel Hodson-Gibbons
Head of eProcurement
NHS Purchasing and Supply Agency

11.00 The Required Authentication Of The Product ID

Several regulations have been set around the world in order to track and trace the medicines through the supply chain and the market. But even if the product gets an individual ID, it must be authenticated. Actually the patients' confidence and the sanitary risk remain the key issues for the pharmaceutical industry

• The need for ID Authentication, why?
• The correlation between Authenticator & ID
  • What should be secured? o How to generate the correlated data?
• A specific space on the secondary packaging component
  • One place for all tags o Tamper-proof for confidence
• Conclusion - The benefits of the approach

Zbigniew SAGAN
Chief Technology Officer Advanced Track & Trace

11.30 Pfizer Overview

• Pfizer experience of what is a counterfeit medicine
• Who is getting involved in the manufacture and distribution of counterfeit pharmaceuticals and why?
• Where are counterfeit medicines a problem?
• How Pfizer is dealing with the problem of counterfeiting

David Shore
Associate Director Global Security
Europe Pfizer

12.15 Creating The Worlds First Pharmaceutical Centre Of Excellence: Demonstrating Mass Serialisation To Meet All Current Legislation For Track And Trace And Authentication.

• Unique data matrix on blister pouch and blister strip
• Hybrid RFID and printed bar codes at case and pallet level
• A fully inter-operable solution
• Software validation and connectivity to all major MES, ERP, WMS systems
• Full documentation to GAMP4, ISO and 21 CFR part 11

Tony Walsh
Business Development, Control
Domino

14.15 Authenticity And Tamper Protection: Tracing Genuine Pharmaceutical Products

• The threat of counterfeiting, manipulation and diversion
• Security packaging has to be effective, reliable, economic and flexible
• Best practice of a “layered approach”
• Protection and tracking along the distribution chains
• Success factors and conclusions

Thomas Voelcker
Director Marketing and Sales
Schreiner Pro-Secure

14.00 BRIDGE: Gaining An Industry Best Practice Insight To The Leading Effort In Harmonising Track And Trace In The Pharmaceutical Industry

• Update on the BRIDGE Project
• The pilot has just being completed: what now?
• Serialisation of Data
• Experiences and lessons learned
• What pharmaceutical companies can now learn?

John Jenkins
BRIDGE Project Co-ordinator
JJ Associates

16.15 Working With Europol To Improve Criminal Investigations

• Collaborating with relevant local law enforcement agencies for efficient investigation and action against the offenders
• Europol’s current medicine anti-counterfeiting activities

Benoit Godart
Seconded Expert, Financial & Property crime Unit
Europol

17.00 Closing Remarks

17.15 End Of Conference

[ Register Now] · [ Next: Pre-Conference Master-Classes: 20th October 2008 ]